drugset
drugset / Trial / NCT03359733

A Study to Evaluate the Effect of Food on the Pharmacokinetics (PK) of TAK-659 in Participants With Advanced Solid Tumor

NCT03359733 ↗

Phase 1 Withdrawn Calithera Biosciences, Inc
RandomizedCrossoverOpen-labelOther

Summary

The purpose of this study is to characterize the effect of food on the single-dose PK of TAK-659 in participants with advanced solid tumors and/or lymphomas.

Timeline

Start
2018-02-28
Primary completion
2019-01-14
Completion
2019-08-20

Drugs

EvaluationDrugModalityDoseRoute
Subject mivavotinib Small molecule 100 mg Oral

Indications

high grade malignant neoplasm lymphoma